300791SZSE
🚨 Material Event

Fifth Announcement Regarding the Put Option for Xianle Convertible Bonds

Sirio Pharma Co., Ltd.··5 pages

✨ AI Summary

This announcement details the fifth reminder for Xianle Convertible Bondholders regarding their put option. The put price is set at RMB 100.7890 per bond. The condition for the put option has been met due to the stock price falling below 70% of the conversion price for thirty consecutive trading days. The put option period is from July 24 to July 30, 2026.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Securities Code: 300791

Bond Code: 123113

Securities Abbreviation: Xianle Health

Bond Abbreviation: Xianle Convertible Bond

Announcement Code: 2026-103

Xianle Health Technology Co., Ltd.

Announcement Regarding the Fifth Reminder for the Put Option of "Xianle Convertible Bond"

The Company and the entire Board of Directors guarantee that the information disclosed is true, accurate, and complete, and contains no false records, misleading statements, or significant omissions.

Special Reminder:

  1. Put Price: RMB 100.7890 per bond (including interest and tax)

  2. Condition Fulfillment Date: July 22, 2026

  3. Put Application Period: July 24, 2026 to July 30, 2026

  4. Issuer Fund Arrival Date: August 4, 2026

  5. Put Payment Date: August 5, 2026

  6. Investor Put Payment Arrival Date: August 6, 2026

  7. Conversion Suspended During Put Period

  8. This Put Option is Not Mandatory

  9. Risk Warning: Investors choosing to exercise the put option is equivalent to selling their "Xianle Convertible Bonds" at RMB 100.7890 per bond (including interest and tax). As of now, the closing price of "Xianle Convertible Bond" is higher than the current put price. Investors choosing to exercise the put option may incur losses. Please be aware of the risks.

Xianle Health Technology Co., Ltd. (hereinafter referred to as the "Company") stock price from June 10, 2026, to July 22, 2026, for thirty consecutive trading days, the closing price was lower than 70% of the current "Xianle Convertible Bond" conversion price of RMB 31.66 per share, which is RMB 22.16 per share. According to the relevant provisions of the "Prospectus for the Offering of Convertible Corporate Bonds by Xianle Health Technology Co., Ltd. on the ChiNext Market to Unspecified Targets" (hereinafter referred to as the "Prospectus"), the conditional put option clause of "Xianle Convertible Bond" has taken effect. The relevant matters of the "Xianle Convertible Bond" put option are hereby announced as follows:

I. Overview of the Put Option

According to the "Prospectus," the provisions of the conditional put option clause are as follows:

  1. Conditional Put Option Clause

In the last two interest-bearing periods of the convertible corporate bonds issued by the Company, if the closing price of the Company's stock is lower than 70% of the current conversion price for any thirty consecutive trading days, holders of convertible corporate bonds have the right to sell all or part of their convertible corporate bonds back to the Company at face value plus accrued interest.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.